Cancer diagnosis and treatment platform based on manganese-based nanomaterials
Frontiers in Bioengineering and Biotechnology · 01.03.2024 · 12
DOI: 10.3389/fbioe.2024.1363569 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 01.03.2024. Verfasst von Jia Fei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Zhuhai Clinical Medical College of Jinan University (Zhuhai People's Hospital), Zhuhai, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer is a leading cause of death worldwide, and the development of new diagnostic and treatment methods is crucial. Manganese-based nanomaterials (MnNMs) have emerged as a focal point in the field of cancer diagnosis and treatment due to their multifunctional properties. These nanomaterials have been extensively explored as contrast agents for various imaging technologies such as magnetic resonance imaging (MRI), photoacoustic imaging (PAI), and near-infrared fluorescence imaging (NIR-FL). The use of these nanomaterials has significantly enhanced the contrast for precise tumor detection and localization. Moreover, MnNMs have shown responsiveness to the tumor microenvironment (TME), enabling innovative approaches to cancer treatment. This review provides an overview of the latest developments of MnNMs and their potential applications in tumor diagnosis and therapy. Finally, potential challenges and prospects of MnNMs in clinical applications are discussed. We believe that this review would serve as a valuable resource for guiding further research on the application of manganese nanomaterials in cancer diagnosis and treatment, addressing the current limitations, and proposing future research directions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Zhuhai Clinical Medical College of Jinan University (Zhuhai People's Hospital), Zhuhai, China.
- Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai Clinical Medical College of Jinan University, Zhuhai, Guangdong, China.
Zitieren
APA
Fei, J., Liu, Y., Zeng, Y., Yang, M., Chen, S., Duan, X., Lu, L., & Chen, M. (2024). Cancer diagnosis and treatment platform based on manganese-based nanomaterials. Frontiers in Bioengineering and Biotechnology, 12. https://doi.org/10.3389/fbioe.2024.1363569
Vancouver
Fei J, Liu Y, Zeng Y, Yang M, Chen S, Duan X, et al. Cancer diagnosis and treatment platform based on manganese-based nanomaterials. Frontiers in Bioengineering and Biotechnology. 2024;12. doi:10.3389/fbioe.2024.1363569
BibTeX
@article{Fei2024,
author = {Fei, Jia and Liu, Yanyan and Zeng, Ya and Yang, Mingqi and Chen, Shanshan and Duan, Xiaobing and Lu, Ligong and Chen, Muhe},
title = {Cancer diagnosis and treatment platform based on manganese-based nanomaterials},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2024},
volume = {12},
doi = {10.3389/fbioe.2024.1363569}
}
EUVIMED